Thumbnail Image
Publication

FDA's Oversight of NECC and Ameridose: A History of Missed Opportunities?

House Committee on Energy and Commerce
Citations
Altmetric:
Abstract
The House Committee on Energy and Commerce issued a Majority Staff Report on a meningitis outbreak related to a contaminated steroid released by the New England Compounding Center.
Date
2013-04-16
Document Type
House Majority Staff Report
Serial Number
Document Length
43 pages
Congress
113
Show all metadata
Files
Thumbnail Image
2013-04-16_R-FDAs_Oversight_NECC-113C.pdf
Adobe PDF, 577.01 KB
URI
https://hdl.handle.net/20.500.14300/2711
Relation
DOI
Keywords
Staff Reports, House, Republican
PAP Major Code
3: Health
PAP Minor Code
321: Regulation of Drug Industry, Medical Devices, and Clinical Labs
Cited Hearings
• House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, hearing on “The Fungal Meningitis Outbreak: Could It Have Been Prevented?” 112th Cong., H.Hrg. 112-181, (2012, November 14)
• Senate Committee on Health, Education, Labor, and Pensions, hearing on “Federal And State Role In Pharmacy Compounding And Reconstitution: Exploring The Right Mix To Protect Patients,” 108th Cong., S.Hrg. 108-378, (2003, October 23)
Press Releases and Contextual Information
https://web.archive.org/web/20130420035522/http://energycommerce.house.gov/press-release/committee-report-meningitis-outbreak-chronicles-fdas-missed-opportunities-to-protect-public-health
Collections
House Committee on Energy and Commerce